ClinicalTrials.Veeva

Menu

Smoking: a Risk Factor for Pulmonary Arterial Hypertension? (DACH)

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Pulmonary Hypertension

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Environmental factors may play a role in the genesis of pulmonary hypertension, especially in endothelial dysfunction. One widespread environmental factor associated with systemic endothelial dysfunction is cigarette smoke. It may well be that cigarette smoking is not only a risk factor for systemic but also for pulmonary vascular diseases and herewith may interact with other risk factors such as a genetic background and associated conditions. The existing studies which deal with this subject are only small single center case control studies providing less data. Therefore a large European multicenter study is necessary.

The investigators hypothesis are:

  • a history of tobacco smoke exposure is highly prevalent in patients with PAH compared to the unaffected general population.
  • a history of tobacco smoke exposure is more prevalent in patients with PAH compared to CTEPH.

Enrollment

500 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pulmonary artery pressure >25mmHg
  • pulmonary capillary occlusion pressure ≤15mmHg

Exclusion criteria

  • pulmonary artery pressure <25mmHg
  • pulmonary capillary occlusion pressure >15mmHg

Trial design

500 participants in 3 patient groups

PAH
Description:
Patients with pulmonary arterial hypertension (PH). PH defined as mean pulmonary artery pressure \>25mmHg with a pulmonary capillary occlusion pressure ≤ 15mmHg
CTEPH
Description:
Patients with chronic thromboembolic pulmonary hypertension. CTEPH defined as mean pulmonary artery pressure \>25mmHg with a pulmonary capillary occlusion pressure ≤ 15mmHg.
Controll group
Description:
Data from 16322 (10336 females) participants of the Swiss health survey (SHS) 2007 will serve as control. The SHS was performed in 2007, a representative sample of 30000 Swiss citizens were asked to participate, 66% answered per telephone to detailed health question.

Trial contacts and locations

9

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems